CH5138303

CH5138303 Basic information
Product Name:CH5138303
Synonyms:CH5138303;Butanamide, 4-[[4-amino-6-(5-chloro-1H,3H-naphtho[1,8-cd]pyran-6-yl)-1,3,5-triazin-2-yl]thio]-;CH5138303_Hsp90;4-[(4-Amino-6-[7-chloro-3-oxatricyclo[7.3.1.0(5,13)] trideca-1(13),5,7,9,11-pentaen-8-yl]-1,3,5-triazin-2-yl)sulfanyl]butanamide;4-[[4-Amino-6-(5-chloro-1H,3H-naphtho[1,8-cd]pyran-6-yl)-1,3,5-triazin-2-yl]thio]butanamide;4-((4-Amino-6-(5-chloro-1,3-dihydrobenzo[de]isochromen-6-yl)-1,3,5-triazin-2-yl)thio)butanamid;4-[4-amino-6-(5-chloro-1H,3H-benzo[de]isochromen-6-yl)-1,3,5-triazin-2-ylsulfanyl]butanamide;CH5138303 USP/EP/BP
CAS:959763-06-5
MF:C19H18ClN5O2S
MW:415.9
EINECS:
Product Categories:Inhibitors
Mol File:959763-06-5.mol
CH5138303 Structure
CH5138303 Chemical Properties
Boiling point 813.1±75.0 °C(Predicted)
density 1.51±0.1 g/cm3(Predicted)
storage temp. Desiccate at -20°C
solubility insoluble in H2O; insoluble in EtOH; ≥19.95 mg/mL in DMSO
form solid
pka16.39±0.40(Predicted)
Safety Information
MSDS Information
CH5138303 Usage And Synthesis
DescriptionCH5138303 is a triazine Hsp90 inhibitor. CH5138303 binds to the N-terminus of Hsp90α (Kd = 0.52 nM) and inhibits growth of HCT116 and NCI-N87 human tumor cell lines in vitro (IC50s = 89 and 66 nM, respectively). CH5138303 also inhibits growth of human NCI-N87 gastric cancer xenografts (ED50 = 3.9 mg/kg) and displays high oral bioavailability in mice.
targetHsp90
references[1]. suda a, kawasaki k, komiyama s, et al. design and synthesis of 2-amino-6-(1h,3h-benzo[de]isochromen-6-yl)-1,3,5-triazines as novel hsp90 inhibitors. bioorg med chem, 2014, 22(2): 892-905.
CH5138303 Preparation Products And Raw materials
17-AAG Luminespib NVP-HSP990(HSP990) 5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide Panobinostat BIIB-021

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.